Prasopoulos Vasileios

Prasopoulos Vasileios Nuclear Radiologist

Director, Nuclear Medicine Department and PET/CT

Education & Academic Qualifications

  • University of Athens School of Medicine (1987)
  • July 1990 – July 1991: Internal Medicine – Polyclinic of Athens
  • August 1991 – December 1994: Νuclear Medicine – Nucl. Medicine Department Alexandra Univ. Hospital – Athens
  • Nuclear medicine in brain imaging (DATSCAN) – 2005 – Parkinson Institute Milan-Polikliniko Milan
  • Training in PET AND PET/CT – 2006 and 2009 – Ludwig Maximilians University in Munich

 

Doctoral thesis

  • February 1995 – Ph.D, Topic: Myocardial scintigraphic study with I-123 MIBG for the assessment of cardiotoxicity – neurotoxicity of Doxorubicin.

Fellowship in Societies, Membership in Journal Editorial Committees

  • Member of Hellenic Society of Nuclear Medicine & Molecular Imaging.

  • Member of E.A.N.M (European Association of Nuclear Medicine).

  • Member of ASNC (American Society of Nuclear Cardiology).

  • Member of SNM (Society of Nuclear Medicine).

  • Member of Medical Society of Athens.

Editorial Boards:

  • Member of the Editorial Board of the European Journal of Nuclear Medicine and Molecular Imaging

  • Member of Editorial Board of “Aktinotechologia” Journal

  • Member of the editorial board of the Journal Nuclear Medicine, Radiology & Radiation Therapy

 

Work Experience

  • February 1995 -April 1995 : Nuclear Medicine Department of Medical Centre of Athens, transferred to Medical Centre of Trikala

  • May 1995 -February 1996: “Centre of Nuclear Medicine of Pireas”

  • June 1996- December 1999: Scientific Director of Nuclear Medicine Department in “IASO” Hospital SA

  • December 1999 -31-5-2006: Director of Nuclear Medicine Department in “IASO” Hospital SA

  • 1/6/2006-today “Hygeia” hospital, Director Nuclear Medicine and PET/CT Department

Education Experience:

  • 1984-1996 teaching:

    • “Α.Κ.Π.Ε.S” laboratory

    • Private school “Ι.Ι.Ε.Κ. SOTIROPOULOU”

  • 1996-1999 Τ.Ε.Ι Athens, “technology of medical instrumentation» Department

  • 14 February 14 1997 – today (Π.Δ 407/80) Scientific collaborator of University of Crete- Medical School

  • Courses in Radiology II- 2nd semester of 2000

  • Courses for trainees in Nuclear Medicine 2001-2002, under the auspices of “Hellenic Association of Nuclear Medicine and Biology”

 

Clinical & Research Interest

Clinical Interest:

  • Nuclear Cardiology

  • Oncology

  • Cardiology

  • Radiology

  • Nuclear Medicine

  • PET-CT and PET-MRI

  • Molecular Imaging

  • PET

  • SPECT

Research Interest:

  • Clinical significance of a positive antimyosin scanning in patients with dilated cardiomyopathy (Sponsored by CENTOCOR – MALLINCKRODT MEDICAL B.V.)

  • Participation of PET/CT Department in multicenter trial of F. Hoffman-La Roche Ltd company

  • Participation of PET/CT Department in multicenter trial of WEBEX TRAINING:Novartis CRAD001N2301 PET Sites

 

Honors & Awards

  • Award to the presentation “The contribution of myocardial scintigraphy with antimyosin in the diagnosis of acute myocarditis” at the 20th Panhellenic Medical Congress.

  • Awards to the presentations at the “EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE CONGRESS 1993″with title:

  • Doxorubicin-induced cardiac neurotoxicity.Study by I-123-metaiodobenzylguanidineSensitivity of dobutamine-thallium imaging is not reduced by beta-blocker therapy αναφέρονται στα HIGHLIGHTS του συνεδρίου Eur.J.Nucl.Med.(1994) 21:159-169 Vol.21,No 2,February 1994

  • Award to the presentation at the” EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE CONGRESS 1997” with title: CARDIAC I-123-METAIODOBENZYLGUANIDINE UPTAKE IN PREDICTING EARLY AND LATE MORTALITY IN PATIENTS WITH CONGESTIVE HEART FAILURE HIGHLIGHTS of the congress Eur.J.Nucl.Med.(1997) 24:1527-1540 Vol.24,No 12,December 1997

  • Award to the presentation at the ”4th International Conference of Nuclear Cardiology”, April 18-21,1999,Athens, Greece with title: THE EFFECTS OF LONG-TERM RIGHT VENTRICULAR APICAL PACING ON CARDIAC SYMPATHETIC INNERVATION : AN 1-123-METAIODOBENZYLGUANIDINE (MIBG) SCINTIGRAPHIC STUDY ¨Best Abstract Award ” 

  • Journal of Nuclear Cardiology Jan/Feb 1999,Vol.6 No.1Part 2:S5.

  • Award to the presentation at the” EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE CONGRESS 1999” με τίτλο: CARDIAC SYMPATHETIC DENERVATION IN CHRONICALLY PACING PATIENTS. AN I-123-METAIODOBENZYLGUANIDINE (MIBG) SCINTIGRAPHIC STUDY HIGHLIGHTS of the congress Eur.J.Nucl.Med.(2000) 27:99-120 Vol.27,No 1, January 2000

  • Award to the presentation: THE EFFECTS OF LONG-TERM RIGHT VENTRICULAR APICAL PACING ON CARDIAC SYMPATHETIC INNERVATION : AN 1-123-METAIODOBENZYLGUANIDINE (MIBG) SCINTIGRAPHIC STUDY as the best announcement with basic research theme from the Hellenic Cardiology Society Athens, 3 March 2000.

  • Award to the presentation “Scintimammography in diagnosis of breast cancer” at the 7th Panhellenic Congress of Mastology 16-19 March Athens Greece.

  • Award to the presentation PET/CT in the estimation of single lung nodule.The role of late images with18F-FDG at the 3d Panhellenic Congress of Oncology Imaging 13-15 December 2013. 

  • Award to the presentation The contribution of PET/CT in the evaluation of response to immunotherapy with Rituximab-CHOP in primary mediastinal B cell lymphoma. Clinical results. 23th Panhellenic Congress of Hematology 2012. 

  • Award to the presentation The correlation between before and after autologous transplantation with 18F-FDG-PET/CT to patients with Hodgkin Lymphoma using different CUTOFF VALUES of the SUVmax from positive or negative PET/CT examination at the 2th Panhellenic Congress of Oncology 9-11 December 

  • Award to the presentation Imaging after therapy to differential thyroid cancer. Can SPECT/CT make the difference? Congress of Oncology Imaging (12/2015) 

 

Books

  • Springer: “Imaging in clinical oncology”.V. Prassopoulos: “PET/CT Clinical Implication of the Role of 18FDG-PET/CT in Malignant Lymphomas” (pp 249, part V).

  • Springer:”PET/CT in Lymphomas: A Case-Based Atlas”, V. Prassopoulos co-editor

 

Recent Publications

  • FLT PET/CT in a Case of Demyelinating Disease. Clin Nucl Med. 2016 Apr 15. [Epub ahead of print]

  • Prospective PET image quality gain calculation method by optimizing detector parameters. Nucl Med Commun. 2015 Dec;36(12):1253-63

  • PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy. Leukemia. 2016 Jan;30(1):238-42.

  • Association between habitual physical activity and brown adipose tissue activity in individuals undergoing PET-CT scan. Clin Endocrinol (Oxf). 2015 Jan;82(1):147-54.

  • A review of PET normalization: striving for count rate uniformity. Nucl Med Commun. 2013 Nov;34(11):1033-45.

  • A rare non-small cell lung cancer (18)F-FDG PET/CT study in a young patient with genetic anomaly living in a highly polluted area. Metastatic lesions not shown by CT. Hell J Nucl Med. 2013 May-Aug;16(2):144-5.

  • Leydig cell tumour of the ovary localised with positron emission tomography/computed tomography. Gynecol Endocrinol. 2011 Oct;27(10):837-9

  • The impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalities. Nucl Med Commun. 2011 Feb;32(2):85-90.